Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.
Komdeur FL, Wouters MC, Workel HH, Tijans AM, Terwindt AL, Brunekreeft KL, Plat A, Klip HG, Eggink FA, Leffers N, Helfrich W, Samplonius DF, Bremer E, Wisman GB, Daemen T, Duiker EW, Hollema H, Nijman HW, de Bruyn M. Komdeur FL, et al. Among authors: hollema h. Oncotarget. 2016 Nov 15;7(46):75130-75144. doi: 10.18632/oncotarget.12077. Oncotarget. 2016. PMID: 27650547 Free PMC article.
Assessment of gene promoter hypermethylation for detection of cervical neoplasia.
Wisman GB, Nijhuis ER, Hoque MO, Reesink-Peters N, Koning AJ, Volders HH, Buikema HJ, Boezen HM, Hollema H, Schuuring E, Sidransky D, van der Zee AG. Wisman GB, et al. Among authors: hollema h. Int J Cancer. 2006 Oct 15;119(8):1908-14. doi: 10.1002/ijc.22060. Int J Cancer. 2006. PMID: 16736496 Free article.
Gynecologic examination and cervical biopsies after (chemo) radiation for cervical cancer to identify patients eligible for salvage surgery.
Nijhuis ER, van der Zee AG, in 't Hout BA, Boomgaard JJ, de Hullu JA, Pras E, Hollema H, Aalders JG, Nijman HW, Willemse PH, Mourits MJ. Nijhuis ER, et al. Among authors: hollema h. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):699-705. doi: 10.1016/j.ijrobp.2006.05.039. Epub 2006 Aug 14. Int J Radiat Oncol Biol Phys. 2006. PMID: 16904839
An overview of innovative techniques to improve cervical cancer screening.
Nijhuis ER, Reesink-Peters N, Wisman GB, Nijman HW, van Zanden J, Volders H, Hollema H, Suurmeijer AJ, Schuuring E, van der Zee AG. Nijhuis ER, et al. Among authors: hollema h. Cell Oncol. 2006;28(5-6):233-46. doi: 10.1155/2006/273547. Cell Oncol. 2006. PMID: 17167177 Free PMC article. Review.
P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapy.
Lambeck A, Leffers N, Hoogeboom BN, Sluiter W, Hamming I, Klip H, ten Hoor K, Esajas M, van Oven M, Drijfhout JW, Platteel I, Offringa R, Hollema H, Melief K, van der Burg S, van der Zee A, Daemen T, Nijman H. Lambeck A, et al. Among authors: hollema h. Int J Cancer. 2007 Aug 1;121(3):606-14. doi: 10.1002/ijc.22710. Int J Cancer. 2007. PMID: 17415711 Free article.
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.
Leffers N, Gooden MJ, de Jong RA, Hoogeboom BN, ten Hoor KA, Hollema H, Boezen HM, van der Zee AG, Daemen T, Nijman HW. Leffers N, et al. Among authors: hollema h. Cancer Immunol Immunother. 2009 Mar;58(3):449-59. doi: 10.1007/s00262-008-0583-5. Epub 2008 Sep 13. Cancer Immunol Immunother. 2009. PMID: 18791714 Free PMC article.
276 results